Get started

RISE

891% RISE in XRP!?? From $0.7 to $7.1Weekly Timeframe Breakout Area / Rejection Area: $0.7979. Bitcoin doesn't have much movement for today as we are in the weekend. but XRP moved for at least 5%. WE are entering a Breakout Area where we would most likely hit our target price of $7.1386. 1D Timeframe From our 144 EMA, Rejection areas are $0.8448 & $0.7948. We are back inside the cloud which means its neutral. RSI is bullish crossing MA. We are yet to see the next Awesome Oscillator (AO) volume, it can print a positive volume to continue the trend to the upside. Relative Strength Volatility Variable Bands (RSVVB) is currently constricting the tunnel preparing for a massive pump. we are ripe for a pump to the upside. Ride before it flies. 4H Timeframe We are holding on to 200 MA which means we are already in the bullish trend. Area of support $0.7505. Rejection Area $0.7876. There might be an incoming correction as our AO is still in negative. 144 EMA and 233 EMA are exactly at the same support area of 200 MA. This means it will be SUPER BULLISH .
Long
by Trade_Scholar
3
Bitcoin Rallies As U.S. Inflation Hits 7% Traders focused on the headline inflation number and rushed to buy riskier assets, including cryptocurrencies. Ethereum, Binance Coin, Solana, Cardano, XRP, Terra are all moving higher as traders look ready to buy all leading coins. While the inflation number itself is scary, traders feared that Inflation Rate will exceed analyst expectations, and the Fed will be forced to act aggressively by raising the interest rate on each meating in 2022. In addition, the Fed has the option to reduce the size of its balance sheet, pushing Treasury yields higher, which will be bearish for all riskier assets, including cryptocurrencies. It is important to note that the market is not treating any cryptocurrency as an inflation hedge. Instead, Bitcoin and other cryptocurrencies are viewed as risky assets, which benefit from lower rates and struggle when the Fed tightens its policy. As inflation met analyst estimates, traders bet that Fed will not make additional moves to tighten its policy, and buy riskier assets like cryptocurrencies. Advertisement
BITSTAMP:BTCUSD
by LenaGraceThomas
1
Update on Silver's Bearish Partial Rise SetupA while back i uploaded a chart pointing out that silver was partial rising within a trading range and that the next time it hit the bottom of the range it'd be much more likely for us to break down and today here we are. I'm reuploading this chart as a relevant reminder of the impending breakout. I expect that we should get a move down to the .786 and .886 area once things really get going. Along with Silver i'm similarly bearish on Gold
TVC:SILVERShort
by RizeSenpai
2
$LGVN entry PT 25 Target PTs 43-49 and higherLongeveron stock is up by a multiple of 11 after the FDA gave a Rare Pediatric Disease designation for a heart medication last week. Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
NASDAQ:LGVNLong
by BADQOMOCAWGOWLD
1
$ISPC entry 14.65-16.15-ish Target PTs 29 and higheriSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
NASDAQ:ISPCLong
by BADQOMOCAWGOWLD
1